Helsinki-based Linio Biotech gets €4.2 million to commercialise its injectable tissue product worldwide

Published on November 22, 2023

Finnish biotech growth company Linio Biotech announced its new €4.2 million investment round, which brings the company’s total funding to over €9 million.  In addition to the previous family offices and private investors, Linio Biotech’s investors will now include new Finnish private investors and doctors familiar with the industry. In the spring of 2023, the…

This content is for members only. Visit the site and log in/register to read.

The post Helsinki-based Linio Biotech gets €4.2 million to commercialise its injectable tissue product worldwide appeared first on EU-Startups.